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Summary 
CD8 + as well as CD4 + T cells and macrophages are of crucial importance for the pathogenesis 
of Borna disease in rats. This virus-induced immunopathological disease of the brain is characterized 
by neurological symptoms in the acute phase and chronic debility associated with severe loss 
of brain tissue in the late stage.  We demonstrate here the cytotoxic activity of T  lymphocytes 
in the brain of intracerebrally infected rats.  T  cells isolated from the brain of infected rats lyse 
major histocompatibility complex (MHC) class I-bearing target cells in the absence of MHC 
class II. Borna disease virus (BDV)-infected syngeneic skin cells and astrocytes, the latter one 
of the relevant target cells in vivo, were significantly lysed whereas infected allogeneic target 
cells were not. Most relevant to the in vivo situation,  primary brain cell cultures propagated 
from the hippocampus of BDV-infected rats containing considerable numbers of neurons were 
lysed in vitro. Blocking experiments using antibodies directed against MHC class I antigen provided 
further evidence for the presence and activity of classical cytotoxic T  lymphocytes. Antibodies 
against MHC class II antigen did not influence lysis of skin target cells but had an effect on 
lysis of astrocytes at late time points.  Lymphocytes isolated from spleen, peripheral blood, or 
lymph nodes did not show cytotoxic activity. These results verify, on the cellular level, earlier 
findings that strongly suggest the involvement of CD8 + T cells in brain cell lesions,  resulting 
in brain atrophy long after infection of rats with BDV. This is further evidenced by the presence 
of CD8 + T cells in direct proximity to neuronal cell lesions. Interestingly, the cytolytic capacity, 
demonstrated in vitro and strongly correlated to organ destruction, does not result in elimination 
of the virus but the virus persists in the central nervous system. 
I 
n addition to horses and sheep as natural hosts, the experi- 
mental infection of individuals of various species with Borna 
disease  virus (BDV), 1 a single-stranded RNA virus (1-3), 
usually results in an encephalomyelitis accompanied by se- 
vere neurological disorders (4-6). Recently, BDV-specific an- 
tibodies have also been detected in humans, indicating that 
humans might harbor a similar or identical agent that is pos- 
sibly involved in psychiatric disorders (7-9). In the rat, the 
most intensively studied experimental animal, intracerebral 
or intranasal infection leads to a persistent, productive infec- 
tion in the central nervous system (10-12) with virus replica- 
tion in neurons, astrocytes, oligodendrocytes, and ependymal 
cells  (10,  13-15). 
By using newborn infected, athymic or immunosuppressed 
1 Abbreviation used in this paper: BDV, Borna  disease virus. 
animals, Borna disease  (BD) was characterized as a virus- 
induced immunopathological disease (10,  16-19).  Antiviral 
antibodies could be excluded from participating in the im- 
munopathological process (10, 18), and the cell-mediated im- 
mune response itself was demonstrated to cause encephalitis 
and disease (reviewed in reference 20). The adoptive transfer 
of BDV-specific CD4 + T cells into tolerant, persistently in- 
fected rats inducing the full-blown disease proved the role 
of T helper cells in Borna disease (21, 22). Furthermore, in- 
formation on the pathogenic importance of CD8 + T  cells, 
which generally have never been successfully established as 
lines or clones from the rat, in BD was provided by use of 
immunomodulatory substances (18, 23) and T  cell-specific 
mAb in vivo (24).  These experiments revealed that CD8 + 
T cells are decisive in triggering a local delayed-type hyper- 
sensitivity reaction in the brain.  Since CD8 + T  cells have 
been  shown  to  cause cytotoxicity in  other virus  models 
(reviewed in reference 25), we have undertaken experiments 
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cytolytic activity in addition  to their immunopathological 
function in BDV-induced encephalitis and disease.  CTL dom- 
inate the initial cellular immune response after many virus 
infections and are effective in eliminating the virus from non- 
neural tissue. However, virus elimination from the brain may 
not be attained, as shown in the lymphocytic choriomenin- 
gitis virus model in mice (26). In the case of noncytopathic 
viruses, as demonstrated here by BDV, an effident immune 
reaction is of considerable disadvantage for the host, which 
results in immune-mediated cell and tissue damage. 
The studies  presented here demonstrate  the presence of 
MHC class I-restricted cytotoxic T cells in the brain but not 
in lymphoid organs of BDV-infected rats. The results sup- 
port our view of the great biological importance of virus- 
specific CD8 + lymphocytes in Borna disease pathogenesis in 
general and for the destruction of virus-infected cells in vivo, 
in particular,  resulting  eventually in organ  atrophy. 
Materials  and  Methods 
Experimental Animals and V/rus.  Lewis female rats obtained from 
the Zentralinstitut  flit Versuchstierzucht (Hannover, Germany) were 
infected at an age of 5 wk by injection into the left brain hemi- 
sphere with 5  x  103 TCID  s~ of BDV. 
Infectivity Assay and Antigen Detection.  Assays  were essentially 
done as described  previously (23).  Briefly, virus infectivity from 
brain homogenates was determined on rabbit embryo brain indi- 
cator cells by indirect immunofluorescence using rat hyperimmune 
sera or BDV-specific mAb  (27,  28).  Virus-specific  antigen  was 
demonstrated in brain homogenates after SDS-gel electrophoresis 
by Western blotting. Detection of the BDV-specific 38/39- and 
24-kD proteins was performed with polyclonal antibodies. 
Induction and Detection of IFN.  IFN-c~/fl was obtained from 
BDV-infected astrocyte cultures at various time points of cultiva- 
tion. The presence of IFN was detected in conventional antiviral 
activity assays using vesicular stomatitis virus as described before 
(29). Briefly, serial twofold dilutions of test supernatants were pre- 
pared and added, together with the indicator cells (a permanent 
cell line from Lewis rat lens epithelium [L1; kindly provided by 
Dr. H. Rink, Institut ~r Strahlenbiologie, Bonn, Germany]), to 
flat-bottomed microtiter plates. Cultures were infected 24 h later 
with 100 ID  5~ of VSV. After another 48 h supernatants were re- 
moved and cells were stained with crystal violet. Test supernatants 
were also dialyzed against  glycin/HC1 buffer (pH 2.0) overnight 
to exclude the presence of IFN-',/. A preparation from L1 cells ob- 
tained after infection with BDV was used as laboratory standard (29). 
Isolation of Effector Cells.  For cytotoxicity assays, lymphocytes 
from various tissues were obtained. Lymphocytes from peripheral 
blood, spleens, and lymph nodes were purified on a Lymphocyte-K 
gradient (Cedarlane Laboratories,  Hornby, Canada) according to 
the manufacturer's specifications. Lymphocytes from the brain were 
isolated by a method previously described by Irani and Griffin (30). 
The animals were anesthetized with ketaminehydrochloride and 
perfused  with  balanced  salt  solution  (BSS). The  brain  was 
homogenized carefully through a stainless steel mesh and collected 
in BSS containing Colhgenase D (0.05%), trypsin inhibitor (TLCK; 
0.1/~g/ml), DNase I (10/~g/ml),  and Hepes (10 mM). The cell 
suspension  was stirred at room temperature for 1 h and allowed 
to settle for 30 min. The supernatant was pelleted at 200 g  for 
5 rain and resuspended in 10 ml Ca/Mg-free PBS. 5 ml of the sus- 
pension was layered on top of 10 ml of a modified RPMI/Ficoll 
gradient and centrifuged at 500g for 30 min. The pellet containing 
the lymphocytes was resuspended in IMDM with 2% FCS, and 
the ceils were counted for further use. 
Propagation of BDV-infected Neurons In VitrcL  Tissue specimens 
of 1 mm  3 were taken from the hippocampus of rats  14 d  after 
BDV infection and propagated in RPMI containing 15% FCS, nerve 
growth factor (10 ng/ml), and Matrigd (50 #g/ml) (Becton Dick- 
inson & Co., Heidelberg, Germany) in 24-well microtiter plates. 
After 4 h, nonadherent tissue particles were removed and control 
wells were stained for typing and viability of the adherent cells. 
The percentage of neurons was then calcuhted by visual counting 
and the cells were immediately used for the cytotoxicity assay. 
Target Cells and MHC Expression.  The following target cells 
were used:  (a) BDV-infected (BDV-F10) and uninfected (NL-F10) 
histocompatible astrocytes  (the homogeneous astrocytic ceU line 
F10, cloned from a primary Lewis [LEW] astrocyte culture by lim- 
iting dilution, was provided by Dr. H. Wekerle, Munich, Germany; 
31); (b) compatible and incompatible skin cell cultures; and (c) pri- 
mary  neuronal  cells. Skin  cell  cultures  were  obtained  from 
2-wk-old Brown Norway (BN) rats, which are histoincompatible 
both at the KT1 (MHC I) and RT2 (MHC II) locus,  and from 
syngeneic LEW rats.  These cultures were designated BDV-BN, 
NbBN (not infected), BDV-LEW,  and NL-LEW (not infected). 
On all calls the expression of MHC antigen using mAbs OX-18 
(class  I)  and  OX-6  (class II)  was  examined  by  indirect  im- 
munofluorescence. 
In  Vitro Treatment of Lymphocytes with Antibody Plus  Comple- 
ment.  Purified lymphocytes were treated at a concentration of 2 
x  106 with a polyclonal rabbit anti-asialo GM1 antibody (1:300; 
Wako Chemicals, D~sseldorf, Germany) plus complement in vitro. 
Cells were incubated with antibodies for 45 min on ice, washed 
twice, and then incubated with 1 ml of a 1:12 dilution of low-tox 
rabbit complement for rat lymphocytes (Cedarlane Laboratories) 
for 30 min at 37~ 
In Vitro Cell-mediated Cytotoxicity.  Aliquots of 107 target cells 
were labeled with 0.2 mCi StCr at 37~  for I h and washed three 
times with medium. The labeled target cells were coincubated with 
effector cells from BDV-infected rats at E/T ratios of 30:1 for brain 
lymphocytes and 100:1 for all other effector lymphocytes, and three- 
fold dilutions of the original concentration in a final volume of 
200/~l/well. Some tests were performed in the presence of mAb 
directed against MHC class I or II determinants. Furthermore, ad- 
herent cells were removed by incubating effector cell populations 
on plastic dishes for 30 rain at 37~  After various periods of time 
(6-18 h), 50-/~1 samples were collected and counted in a gamma 
counter. The percentage of SlCr release was calculated  according 
to the formula: 100x  (test release  -  spontaneous release)/(max- 
imum release  -  spontaneous release), where test release is in the 
presence of effector cells, spontaneous release is in the presence of 
medium alone, and maximal release is by 1 N  HC1. Spontaneous 
release never exceeded 25%. Cytotoxicity  of  brain lymphocytes from 
BDV-infected rats against  BDV-infected hippocampal cells propa- 
gated ex vivo was determined 6 h after cocultivation. After removing 
the medium, the plates were washed in PBS and the adherent cells 
were fixed and stained  with cresyl violet or with neurofilament- 
specific antibodies to identify neurons. The cytotoxicity was then 
calculated by visual counting of the vital neurons in the test wells 
in comparison with wells containing neurons from uninfected rats 
and with wells containing BDV-infected neurons that were cov- 
ered with anti-MHC class I antibody OX-18  1 h before adding 
the effector cells. 
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cells for the expression of BDV and MHC antigen,  the indirect 
immunofluorescence  technique was used. Ceils were fixed with ace- 
tone for 20 rain and for 10 rain in chloroform at room tempera- 
ture. Nonspecific  staining was blocked by incubation with undiluted 
porcine serum for 30 min.  After several washings with PBS the 
primary antibodies were incubated for 60 min at room tempera- 
ture:  mAb OX-18 (MHC class I,  1 mg/ml;  1:100), mAb OX-6 
(MHC class II, 1 mg/ml;  1:100), mAb 38/15H7 (BDV; 1:100), 
mAb NR4 (neurofilament, 68 kD; 1:100). Surface expression of 
MHC antigens was determined on BDV-infected and uninfected 
cells without fixation in the presence of sodium azide in the cold. 
After several washes FITC-labded secondary antibodies (Sebak, 
Aidenbach, Germany) were added for 60 min at 4~  at concentra- 
tions of 1:50. The slides were finally mounted with PBS/antifade 
solution. Double immunofluorescent staining of  neurofilaments  and 
MHC class I antigens was performed by use of the avidin-biotin 
method with FITC for the anti-neurofilament (NF) 68-kD mAb 
NR4 and a Texas red-coupled anti-mouse IgG for visualization 
of Ox-18. 
Anti-T Cell Treatment of Rats.  BDV-infected rats were treated 
with mAbs directed against the CD8 (OX-8) or CD4 molecule 
(W3/25) as reported earlier (20). 
Histology.  Brain  tissue  was  removed immediately  after  the 
animals were killed and either frozen in isopentane at  -150~  or 
fixed in buffered formalin. Sections were stained with hematoxylin 
and eosin of Nissl stain. Reduction of  brain tissue in BDV-infected 
rats was calculated as follows: mean diameter of the dorsal cerebral 
cortex of all animals in a group (BDV-infected  and either untreated 
or treated in vivo with the CD8-specific mAb OX-8 or the CD4- 
specific mAb  W3/25).  Measurement  was  performed  in  three 
different frontal sections according to the rostro-caudal coordinates 
corresponding  to 0-0.6, 2.6-3.6, and 4.6-5.6 of the coordinate 
system of de Groot (32). 
Results 
Antigen Expression by Target Cells.  All BDV-infected cell 
cultures were shown to express BDV-specific antigens, as de- 
tected by indirect immunofluorescence using polyclonal rat 
sera or mouse mAb (Fig.  1 A). Furthermore, the expression 
of MHC antigens in BDV-infected and uninfected cells was 
tested. Both astrocyte and skin cell cultures, irrespective of 
whether infected or not, spontaneously expressed MHC class 
I antigen as detected by mAb OX-18 (Fig.  1 B). In contrast, 
neither skin cells (Fig.  1 C) nor astrocytes expressed detect- 
able amounts of MHC class II antigen spontaneously, the 
latter results confirming our previous findings (31). Distinct 
Ia antigen expression could only be induced by pretreatment 
with rlFN-'y (20 U/ml) on astrocytes (31) but not on skin 
cell cultures, as shown by using the MHC class II-specific 
mAb OX-6 (Fig. 1 D). Thus, BDV-infected cells used as target 
cells in cytotoxicity assays only expressed MHC class I an- 
tigen. Additionally, we included experiments to determine 
whether infected astrocytes can produce IFN in vitro, which 
might  result  in  an  upregulation  of MHC  antigens  after 
Figure  1.  BDV antigen  and MHC antigen  expres- 
sion on target cells. Presence  of  BDV-specific  antigen 
(A, BDV-specific  mAb) and MHC class I antigen (B, 
mAb OX-18), absence  of  MHC class  1I antigen  without 
further  treatment  (C, mAb OX-6)  and after  treatment 
with rlFN-'y (100 U/ml; D, mAb OX-6), and con- 
trol for FITC-labeling  without primary  antibody  (E) 
on infected  LEW skin fibroblasts. 
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Testing of supernatants from BDV astrocytes revealed no an- 
tiviral activity at 12 h, whereas maximally 100-220 U  was 
found in BDV-F10 supernatants beyond this time point (Fig. 
2). After 48 h of incubation, ceils tested for expression of 
MHC antigens revealed the presence of class I but not class 
II antigens. Since treatment of supernatants at pH 2 did not 
result in the reduction of antiviral activity (data not shown), 
these results argue for the presence of IFN-a//~ and the ab- 
sence of IFN-% which might have induced MHC class II 
antigen in target cell cultures. 
Presence of Cytotoxic T Cell Activity in Lymphocyte Prepara- 
tions  from the Brain.  Testing of lymphocytes isolated from the 
brain of BDV-infected rats between days 10 and 21 postinfec- 
tion revealed differences in their capacity to lyse virus-infected 
target cells. Whereas only very few brain lymphocytes without 
lytic activity were present at day 10 postinfection, high lysis 
was found beyond day 14, in parallel with or preceding the 
onset of clinical symptoms for 1 d (data not shown). Since 
the largest numbers of lymphocytes could be isolated on day 
21 postinfection, this time point was chosen for all subse- 
quently described experiments. Day 21 BDV-immune brain 
lymphocytes were coincubated with infected (BDV-LEW) 
and uninfected (LEW) skin cultures (Fig. 3, A and B). After 
6 h of coincubation, moderate cytotoxic activity could be 
detected ranging from 20 to 40% in five independent experi- 
ments; at 9 h, high lysis (45-70%) of BDV-LEW was found 
whereas uninfected target cells were not lysed. As relevant 
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Figure  2.  Antiviral activity in supernatants  from BDV-infected rat as- 
trocytes. Supernatants  of cultures were titrated  on rat lens epithelial cells 
for protection against  the cytopathic  effect of vesicular stomatitis  virus. 
Titers  given are units of IFN found to protect  50%  of indicator  cells. 
target cells to the in vivo situation, BDV-infected astrocytes 
were also tested in cytotoxicity assays. It was found that lysis 
of astrocytes  was insignificant at 6 h,  increased until 9 h 
to signifcant values, and cytotoxicity reached a maximum 
between 12 and 18 h (Fig. 3, C and D). These kinetics were 
highly reproducible for both types of target cells used. 
Absence of Cytotoxic Activity.from Lymphoid Organs.  After 
the presence of cytotoxic cells had been established in the brain, 
it was of interest to determine whether cytotoxic activity could 
also be found in lymphocyte preparations from other lym- 
phoid tissue.  Therefore, lymphocytes were purified from 
spleen,  peripheral blood, and abdominal lymph nodes and 
compared with lymphocytes isolated from the brains of the 
same animals in cytotoxicity assays. Cytotoxic activity could 
not be detected in lymphocytes from BDV-infected rats at 
day 21 postinfection apart from brain lymphocytes (Fig. 4). 
Additional testing of lymphocytes isolated from the blood 
of infected rats at earlier  time points surprisingly revealed 
the same results (data  not shown). 
BDV-specific Brain Effector Cells Are MHC Restricted.  After 
the cytotoxic activity of brain lymphocytes had been estab- 
lished on MHC class I-bearing skin ceU cultures, experiments 
were performed to prove MHC restriction. Therefore, cyto- 
toxicity assays were performed on compatible (BDV-LEW) 
and incompatible (BDV-BN) skin fibroblast target ceUs. Syn- 
gendc skin cells were clearly lysed whereas incompatible BDV- 
infected skin cells from BN rats were not (Fig. 5 A). Both 
types of skin target ceils were from persistently BDV-infected 
cultures in which 100% of the cells were found positive for 
virus-specific antigen by immunofluorescence  or Western blot 
analysis with BDV-specific rat antisera or mAbs. Virus titers 
obtained after freezing and thawing of all infected cells were 
fully comparable (data not shown). Depletion of adherent 
calls from the effector  cell population did not result in a 
different reaction pattern, and the possible presence of NK 
cells in effector cell populations was excluded by cytotoxicity 
assays on NK-sensitive YAC-1 target cells. (Fig.  5 B). 
Treatment of effector lymphocytes with anti-asialo GM1 
antibody, a common marker of NK cells and of the majority 
of CD8 + T  cells in the rat, resulted in a complete absence 
of lysis (Fig. 5 C). Furthermore, blocking experiments with 
mAb OX-18 (anti-MHC class I) were performed. Lysis of 
syngeneic skin target cells was completely inhibited by anti- 
MHC class I antibodies (Fig. 5 D). Since lysis on astrocytes, 
which had been shown to be capable of expressing MHC 
class II antigen, had increased at time points later than 9 h, 
possibly due to IFN-'y induction during the coincubation 
of effector lymphocytes and target cells, we also tested whether 
anti-MHC dass II had any influence on the lysis of infected 
astrocytes. The presence of anti-MHC class I antibody again 
resulted in a significant  decrease (75-85%) of cytotoxicity 
at 9 h. However, some reduction in lysis (20-35%) was also 
found of anti-MHC class II antibody, whereas an irrelevant 
isotype-matched  influenza nucleoprotein-specifc mAb did not 
reduce lysis (Fig.  5 E). 
Lysis of BDV-infected Brain Cells In Vitro  Primary brain 
cell cultures obtained from BDV-infected rats were also used 
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Figure 3.  Lysis  of histocorapatible target cells by 
lymphocytes isolated from the brain of BDV-infected 
rats. Kinetics of cytotoxicity  on skin fibroblasts at 6 
(A) and 9 h (B), and on astrocytes  at 9 (C) and 12 h (D). 
as target cells in cytotoxicity assays. These cultured ceils were 
characterized in vitro to contain numerous neurons, as shown 
by immunofluorescence with a neurofilament-specific mAb, 
and express MHC class  I antigen  (Fig.  6). However, since 
primary neuronal cultures are known to be particularly sensi- 
tive to manipulations,  e.g., SlCr labeling, viability of neuro- 
filament-containing cells, i~., neurons, after coincubation with 
effector cells was determined.  As can be seen from Fig.  7 
neurons as relevant target cells to the in vivo situation were 
significantly lysed in vitro during a 6-h cytotoxicity assay. 
Demonstration of  Brain Cell Lesions In Vivo  and Effect of  Anti-T 
Cell Antibodies.  To correlate the in vitro findings on cyto- 
toxic T cell activities with the in vivo situation, histological 
examination of brains from BDV-infected rats was performed. 
Simultaneously with the appearance of inflammatory reac- 
tions, first neuronal degenerations were found in the brain 
(Fig.  8 A).  Additionally,  severe astrocytic and perivascular 
edema was seen (Fig. 8 B). Brain cell lesions occurred in di- 
rect proximity of CD8 + cells (Fig. 8 C). The severeness  of 
brain destruction in BDV-infected rats not treated with CD8- 
specific mAb is shown (Fig.  9 A) at day 50 postinfection. 
Adult BDV-infected animals show a reduction of brain tissue 
of ,,o60% as compared with uninfected rats (Fig. 10). In con- 
trast,  no inflammatory reaction (24) and little brain tissue 
loss were found in rats treated with antibody OX-8 directed 
against CD8 § T  cells (Fig.  9 B), whereas anti-CD4-treated 
BDV-infected rats still showed significant loss of brain sub- 
stance (Fig.  10).  In all rats,  however, virus-specific antigen 
as detected by Western blot analysis and immunohistochem- 
istry on the one hand and in  situ hybridization  (data not 
shown),  and infectious virus as shown in infectivity assays 
on the other hand, persisted in the brain (Fig. 10). The virus 
liter on the per gram basis was not different in BDV-infected 
rats showing severe brain atrophy than in BDV-infected and 
OX-8-treated  rats without  tissue degeneration. 
Discussion 
Lymphocytes isolated from the brain of rats infected with 
BDV exert cytolytic activity on BDV-infected target cells in 
a MHC class I-restricted manner.  Effectors exhibited cyto- 
toxic activity on primary neuronal cells cultivated from BDV- 
infected syngenic Lewis rats and lysed syngeneic infected skin 
cells but  did  not  exert  cytotoxicity on  aUogeneic MHC- 
mismatched  skin cells  obtained from BN rats.  In addition 
to MHC restriction,  experiments using mAb to block the 
recognition of MHC molecules on target cells clearly showed 
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Figure 4.  Presence  ofcytotoxic activity in lymphocyte 
preparations from various tissues. Lymphocytes were iso- 
lated  from  the  indicated  tissues  by  Ficol] gradients 
(Lympholyte-R) and tested in a 9-h assay. Note the different 
E/T ratios. 
that lysis was mediated by classical  MHC class I-restricted 
cytotoxic T  cells. 
We previously showed that CD8 + T  cells are of patho- 
genic importance in BD and contribute most to the acute 
immunopathological disease, particularly shown by the in- 
crease of CD8 + cell numbers in parallel with the onset of 
the disease (23, 24). In addition to acute Borna disease there 
are drastic chronic affects on the central nervous system (33). 
A severe hydrocephalus internus can be found in rats infected 
with BDV. This hydrocephalus does not result secondarily 
from hydrocephalus occlusus (34) or from hypoxia (our un- 
published observation). As morphologic parameter of the pro- 
cess leading to the destruction of brain tissue, necrosis of brain 
cells, as represented by severe astrocytic and perivascular edema, 
as well as nerve cell degenerations have been seen (Fig. 8). 
Similar pathological changes in the brain tissue, suggested 
to be due to immune-mediated lysis,  were observed earlier 
(10);  however, no direct evidence for immunopathological 
destruction or the cell responsible for the loss of brain tissue 
has yet been provided (10,  13,  14,  35). 
The prime immune response to eliminate virus from the 
host is the generation of CTL that recognize virus-specific 
determinants together with the class I MHC, a glycoprotein 
expressed on the surface of most host cells in the body (36, 37). 
In this study, we could demonstrate the cytolytic activity 
of MHC class I-restricted lymphocytes isolated from the brain 
of infected animals. The lysis exerted by BDV-specific rat lym- 
phocytes was delayed and therefore the kinetics were different 
from mouse cytotoxicity assays  that  only take maximally 
4-6 h. However, rat CTL specific for vaccinia virus or directed 
against tumor determinants also show protracted lytic acti- 
vity in vitro (38, 39). Antibody-mediated cytotoxicity opera- 
tive in BD can be excluded for several reasons: first, treatment 
of BDV-infected rats with suboptimal doses of cyclosporine A 
or anti-CD4 mAb treatment resulted in the inhibition of virus- 
specific antibody synthesis but could not inhibit encephalitic 
lesions and disease (18, 24); second, pathological changes in 
the brain can be observed before antibodies are detectable; 
and third,  athymic rats synthesize virus-specific antibodies 
but do not show encephalitis (17).  NK cell activity could 
be excluded experimentally in vitro by assays using the NK- 
sensitive target cell YAC-1; furthermore, astrocytes (40) and 
occasionally fibroblasts (41), which were used in this study, 
do not serve as NK targets. In lack of a complement-binding 
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Figure 5.  MHC  restriction  of 
CTL isolated  flora the brain of BDV- 
infected rats. (A) Absence of lysis 
on  allogeneic  MHC-mismatched 
skin fibroblast targets from BN rats. 
(B) Lysis  of BDV-infected  target cells 
without further treatment of brain 
effector cells (,)  and after deple- 
tion of  m=ro#~s (m; absence  of 
significant NK activity on YAC-1 
target cells (D). (C) Loss of lyric 
activity of  brain lymphocytes on in- 
fected  syngeneic  skin  fibroblasts 
after treatment with antibodies to 
the  NK/CD8 §  T  cell  marker 
asialo GM1. (D) Inhibition  of lysis 
in the presence of anti-MHC class 
I antibody (mAb OXd8) on LEW 
skin fibroblasts. (E) Effect of anti- 
bodies against MHC class I and II 
(mAbs OX-18 and OX-6)  and an 
irrelevant  isotype-matched  mAb 
(N5G5) on lysis of BDV-infected  as- 
trocytes. Figure 6.  Expression  of MHC class I antigen on BDV- 
infected  hippocampus  neurons  propagated  in vitro from rats 
14 d postinfection  for brain lymphocyte-mediated  cytotox- 
icity  assay.  Immunofluorescence  double  staining  with an anti- 
neurofalament mAb  (A)  and  anti-MHC class I  mAb 
OX-18 (B). Presence  of BDV antigen was tested in parallel 
staining (not shown) (x240). 
mAb specific for rat CD8 + ceils, the T  lymphocyte pheno- 
type of  cytotoxic ceils was confirmed  using an anti-asialo GM1 
antibody that was able to fix complement. The asialo GM1 
marker is expressed on NK ceUs and the majority of CD8 + 
T cells in the rat (42). Antibodies directed against asialo GM1 
can readily abrogate cytotoxic activity of virus-specific T cells 
(43). Treatment of effector cells with the antibody completely 
abrogated lysis of target cells, confirming that CTL are oper- 
ative in MHC-restricted lysis of BDV-infected target ceils. 
Despite the activity of cytotoxic cells, BDV persists in the 
brain. This phenomenon remains to be investigated more thor- 
oughly. This finding is not unique since a similar situation 
has been reported for lymphocytic choriomeningitis virus in- 
fection in mice, in which virus clearance is not accomplished 
despite the presence of cytotoxic T  cell activity (26).  It can 
be envisaged that in vivo the cytotoxic T cell response might 
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Figure 7.  Lysis  of  primary  neuronal  cell  cultures  by BDV effector  lym- 
phocytes (6-h assay). 
occur too late with regard to a limitation of virus replication 
at an early stage of infection, since the virus spreads readily 
and quickly throughout the brain. 
Interestingly, no cytotoxic T cell activity was found in pe- 
ripheral lymphoid tissue preparations 21 d postinfection. Ad- 
ditional testing of lymphocytes purified from the peripheral 
blood of infected rats between days 5 and 15 also failed to 
reveal antigen-specific cytotoxic activity. A similar observa- 
tion  has  been  reported  for  hepatitis  C  virus  infection in 
humans, where no virus-specific cytotoxic T cell activity was 
detectable in PBL from patients in which hepatitis C virus- 
specific cytotoxic ceils were found among liver-infiltrating 
lymphocytes (44).  In BD, this finding might be attributable 
to a low frequency of BDV-specific cytotoxic T  ceils in the 
periphery and the subsequent and selective homing of acti- 
vated cells from the periphery to the site of antigen presenta- 
tion and tissue damage. However, we cannot exclude that 
CD8 + T cells also might be directly stimulated locally, e.g., 
by dendritic cells and astrocytes (45-48). It is of note in this 
respect that BDV antigen is present only in the nervous system 
of adult infected rats and virus does not measurably replicate 
outside the nervous system (49).  However, it is also known 
that intracerebral infection results in the presence of virus 
in the periphery (50),  and we have provided evidence for an 
early peripheral priming of virus-specific T cells in BD (18). 
MHC class I antigen has been demonstrated in the brain 
of BDV-infected rats (15,  23).  Here we show the presence 
of MHC class I antigen on neuronal cultures ex vivo.  Al- 
though, under normal conditions, the nervous system and 
especially neural cells have low levels of MHC antigen, greater 
expression occurs during pathologic situations (51, 52). This 
notion is supported by observations that IFN-3' induces MHC 
class I antigen expression on cells of neuronal origin (53, 54). 
Whereas no conspicuous dass II antigen expression was found 
on neurons in BD,  astrocytes also  expressed MHC class II 
antigen. Taking this in vivo finding into account, we inves- 
tigated which MHC antigens were expressed on the surface 
of the target cells used in this study. In addition to skin fibro- 
blast we performed cytotoxicity assays on targets relevant to 
the in vivo situation, namely on neuronal and astrocyte cul- 
tures persistently infected with BDV.  Whereas MHC class 
II antigen could not be detected on fibroblasts in the present 
170  Cytotoxic  T Lymphocyte  Activity  in Brain Tissue Destruction Figure  8.  Pathological  lesions to the brain of 
BDV-infected rats.  Severe astrocytic  and  perivas- 
cular edema (A) as well as nerve cell degenerations 
(B) in the cortex and the hippocampus  formation 
at day 14 postinfection.  Note the direct proximity 
of immunostained CD8 + cells to the nerve cells 
(C). Arrows, astrocytes; arrowheads,  neurons. (A and 
B)  Nissl  staining;  (C)  ABC-immunoperoxidase 
staining  with  mAb  Ox-8,  counterstained  with 
hemalaun. 
171  Planz  et al. Figure  9.  Brain cell atrophy  in BDV-infected rats. (A) 
Severe  brain atrophy is observed in an adult untreated  LEW 
rat 50 d postinfection  with a "burned-out" inflammation. 
(B) The brain of a BDV-infected rat treated with mAb OX-8 
in  vivo  without  atrophy  and  signs  of  inflammation. 
Hematoxylin-eosin  staining;  x80. 
study or in a previous report (55), and neurons did not show 
conspicuous MHC class II antigen expression in vivo (Bilzer, 
T.,  and L.  Stitz,  manuscript in preparation),  astrocytes ex- 
pressed MHC class II antigen only after induction with IFN-3, 
(31, 56). IFN produced by BDV-infected astrocytes did not 
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Figure  10.  Reduction of  brain substance in BDV-infected rats with and 
without anti-T cell antibody treatment at day 70 postinfection  (OX-8, 
anti-CD8;  W3/25,  anti-CD4).  For calculation  of tissue  reduction see 
Materials and Methods.  Virus titers are given on the per gram tissue basis 
determined by end-point titrations. 
induce Ia antigen expression on indicator cells. This result 
agrees with the finding that IFN-ot/B, and in particular IFN 
produced by astrocytes, upregulates MHC dass I but not class 
II expression (57,  58).  Furthermore, blocking experiments 
with anti-MHC class I antibodies demonstrated the restric- 
tion specificity of the cytotoxic T  cells.  However, the fact 
that blocking was not complete and cytotoxicity could be 
found after prolonged periods of time (12 h) on astrocytes, 
indicating the characteristic kinetics of lysis from MHC class 
II-restricted T  cells, Ia-restricted CTL might be present in 
the brain of BDV-infected rats. This interpretation agrees with 
the reported cytotoxic activity of a BDV-specific CD4 + T 
cell line (31).  There virus-specific T  cells might participate 
in the pathogenic process of late changes by direct action on 
MHC class II-bearing astrocytes, which indirectly may re- 
sult in effects on neurons. For formal reasons we therefore 
cannot exclude that CD4 + T  cells might contribute to the 
destruction of brain tissue.  However, there is no significant 
MHC class II antigen expression on neurons in BDV-infected 
rats, whereas various other cell types in the brain express high 
levels of this antigen (Bilzer, T., and L. Stitz, in preparation) 
and treatment with mAb directed against CD4 § T cells still 
resulted in a loss  of brain tissue of >50%  vs.  only 10%  in 
anti-CDS-treated BDV-infected rats. Therefore we conclude 
that  the impact of CD4 + T  cells may be little.  The very 
limited brain cell degeneration in anti-CDS-treated rats might 
reflect some interference of BDV with the cellular metabo- 
lism, as suggested recently by Carbone et al. (12). Wong et 
al.  (54),  and more recently Joly et al.  (59),  have discussed 
the possibility that neuronal cells evade immunopatholog- 
ical destruction by lack of MHC  class  I  expression.  The 
findings here suggest that this pathway for neurons to escape 
cellular defense mechanisms may not be generalized. 
In conclusion, the activity of CD8 + T  cells obviously is 
not only important in the early phase of BD, where it ap- 
172  Cytotoxic T  Lymphocyte  Activity in Brain  Tissue Destruction pears to be decisive in triggering the local CD4 + T  cell- 
mediated delayed-type hypersensitivity reaction, but also ap- 
parently predominates in the mechanisms of the destruction 
of brain cells, leading to atrophy and clinically to dementia 
and chronic debility. Therefore, BD in rats provides an in- 
teresting model to study immunopathological mechanisms 
active during persistant virus infections and also appears to 
be a unique model to investigate T  cell-mediated tissue de- 
struction in vivo. 
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